Linde | LIN - Equity Capital And Reserves


Linde reported $40.09B in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Air Products & Chemicals USD 15.65B 238.6M Mar/2026
Acerinox EUR 2.14B 38.37M Mar/2026
Air Liquide EUR 26.21B 1.7B Dec/2025
Akzo Nobel EUR 4.88B 222M Mar/2026
Arkema EUR 6.96B 913.9M Mar/2026
BASF EUR 33.2B 434M Dec/2025
Bayer EUR 28.85B 2.9B Mar/2026
Corteva USD 24.36B 218M Mar/2026
Covestro EUR 7B 908M Dec/2025
Dow USD 15.25B 759M Mar/2026
Dupont De Nemours USD 14.04B 121M Mar/2026
Henkel EUR 20.5B 459M Dec/2025
Huntsman USD 2.68B 69M Mar/2026
Johnson Matthey GBP 2.02B 85M Jun/2026
Linde USD 40.09B 1.85B Mar/2026
LyondellBasell Industries USD 10.04B 42M Mar/2026
Merck EUR 29.74B 1.15B Mar/2026
PPG Industries USD 8.1B 163M Mar/2026
Sherwin-Williams USD 4.43B 167.2M Mar/2026
Sika AG CHF 6.66B 481.4M Dec/2025
Solvay EUR 1.18B 161M Mar/2026
Umicore EUR 2.24B 195.4M Dec/2025
Westlake Chemical USD 8.55B 245M Mar/2026